Skip to search formSkip to main contentSkip to account menu

cimoxatone

Known as: 3-(4-(3-cyanophenylmethoxy)phenyl)-5-(methoxymethyl)-2-oxazolidinone, Benzonitrile, 3-((4-(5-(methoxymethyl)-2-oxo-3-oxazolidinyl)phenoxy)methyl)- 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

MD 780515

Broader (2)

Monoamine Oxidase InhibitorsOxazolidinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Determination of 2-phenylethylamine in rat brain after MAO inhibitors, and in human CSF and urine by capillary GC and chemical ionization MS
A highly specific and sensitive method for the determination ofβ-phenylethylamine (PEA) in biological material is presented. It… 
2004
2004
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone
The effects of cimoxatone, a reversible inhibitor of monoamine oxidase type A (MAO-A), on the deaminated metabolites of… 
1988
1988
Alterations of serotonin neurotransmission and inhibition of mouse killing behavior: II. Effects of selective and reversible monoamine oxidase inhibitors of type A
Review
1988
Review
1988
Basic and clinical aspects of the activity of the new monoamine oxidase inhibitors.
The clinical relevance of the neurobiochemical and pharmacological properties of the new generation of monoamine oxidase… 
1984
1984
Discrimination of the amphetamine cue Effects of A, B and mixed type inhibitors of monoamine oxidase
1984
1984
Pharmacokinetic and relative bioavailability studies of cimoxatone in humans.
The pharmacokinetics of the reversible MAO-A inhibitor, cimoxatone, and its O-demethyl metabolite MD 770222 were investigated in… 
1983
1983
Oral absorption and concentration‐effect relationship of tyramine with and without cimoxatone, a type‐A specific inhibitor of monoamine oxidase
The mechanism of increased sensitivity to oral tyramine in patients taking monoamine oxidase inhibitors was investigated by… 
1983
1983
The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222
SummaryIn both rat brain and heart, noradrenaline and 5-hydroxytryptamine are metabolised predominantly by monoamine oxidase-A… 
1983
1983
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
Cimoxatone is a new monoamine oxidase inhibitor (MAOI) in comparison to the existing non-selective and irreversible MAOIs used in… 
1983
1983
Plasma protein binding of the reversible type A MAO inhibitor cimoxatone (MD 780515).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)